BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23329453)

  • 41. Selective breast cancer cell capture, culture, and immunocytochemical analysis using self-assembled magnetic bead patterns in a microfluidic chip.
    Sivagnanam V; Song B; Vandevyver C; Bünzli JC; Gijs MA
    Langmuir; 2010 May; 26(9):6091-6. PubMed ID: 20364860
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ImmunoMembrane: a publicly available web application for digital image analysis of HER2 immunohistochemistry.
    Tuominen VJ; Tolonen TT; Isola J
    Histopathology; 2012 Apr; 60(5):758-67. PubMed ID: 22296215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microfluidic cell culture chip with multiplexed medium delivery and efficient cell/scaffold loading mechanisms for high-throughput perfusion 3-dimensional cell culture-based assays.
    Huang SB; Wu MH; Wang SS; Lee GB
    Biomed Microdevices; 2011 Jun; 13(3):415-30. PubMed ID: 21234690
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Integrated microfluidic platform for the electrochemical detection of breast cancer markers in patient serum samples.
    Fragoso A; Latta D; Laboria N; von Germar F; Hansen-Hagge TE; Kemmner W; Gärtner C; Klemm R; Drese KS; O'Sullivan CK
    Lab Chip; 2011 Feb; 11(4):625-31. PubMed ID: 21120243
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biofabrication of a three-dimensional liver micro-organ as an in vitro drug metabolism model.
    Chang R; Emami K; Wu H; Sun W
    Biofabrication; 2010 Dec; 2(4):045004. PubMed ID: 21079286
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amplification of the HER2 gene in breast cancers testing 2+ weak positive by HercepTest immunohistochemistry: false-positive or false-negative immunohistochemistry?
    Barrett C; Magee H; O'Toole D; Daly S; Jeffers M
    J Clin Pathol; 2007 Jun; 60(6):690-3. PubMed ID: 16822876
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microfluidic devices for in vitro studies on liver drug metabolism and toxicity.
    van Midwoud PM; Verpoorte E; Groothuis GM
    Integr Biol (Camb); 2011 May; 3(5):509-21. PubMed ID: 21331391
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Her-2 amplification and p185 expression in invasive breast cancer cells in women].
    Titi S
    Ann Acad Med Stetin; 2006; 52(2):5-12. PubMed ID: 17633393
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiplexed immunohistochemistry, imaging, and quantitation: a review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis.
    Stack EC; Wang C; Roman KA; Hoyt CC
    Methods; 2014 Nov; 70(1):46-58. PubMed ID: 25242720
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation of GREB1 mRNA with protein expression in breast cancer: validation of a novel GREB1 monoclonal antibody.
    Hnatyszyn HJ; Liu M; Hilger A; Herbert L; Gomez-Fernandez CR; Jorda M; Thomas D; Rae JM; El-Ashry D; Lippman ME
    Breast Cancer Res Treat; 2010 Jul; 122(2):371-80. PubMed ID: 19842031
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Breast cancers presenting luminal B subtype features show higher discordant human epidermal growth factor receptor 2 results between immunohistochemistry and fluorescence in situ hybridization.
    Park S; Park HS; Koo JS; Yang WI; Kim SI; Park BW
    Cancer; 2012 Feb; 118(4):914-23. PubMed ID: 21800290
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Concordant HER2 status between metastatic breast cancer cells in CSF and primary breast cancer tissue.
    Park IH; Kwon Y; Ro JY; Lee KS; Ro J
    Breast Cancer Res Treat; 2010 Aug; 123(1):125-8. PubMed ID: 19916047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A microfluidic device with passive air-bubble valves for real-time measurement of dose-dependent drug cytotoxicity through impedance sensing.
    Xu Y; Lv Y; Wang L; Xing W; Cheng J
    Biosens Bioelectron; 2012 Feb; 32(1):300-4. PubMed ID: 22208957
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Comparison of fluorescence in situ hybridization and immunohistochemistry assessment for Her-2 status in breast cancer and its relationship to clinicopathological characteristics].
    Li HH; Ma F; Zeng X; Wang JY; Yuan P; Fan Y; Xu BH
    Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(2):76-80. PubMed ID: 21418986
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiplexed tandem polymerase chain reaction identifies strong expression of oestrogen receptor and Her-2 from single, formalin-fixed, paraffin-embedded breast cancer sections.
    Thompson EW; Warton K; Blick T; Wafai R; Hill P; Stanley K
    Pathology; 2010 Feb; 42(2):165-72. PubMed ID: 20085519
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A 3-D microfluidic combinatorial cell array.
    Liu MC; Tai YC
    Biomed Microdevices; 2011 Feb; 13(1):191-201. PubMed ID: 21063783
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiplexed Immunohistochemical Consecutive Staining on Single Slide (MICSSS): Multiplexed Chromogenic IHC Assay for High-Dimensional Tissue Analysis.
    Akturk G; Sweeney R; Remark R; Merad M; Gnjatic S
    Methods Mol Biol; 2020; 2055():497-519. PubMed ID: 31502167
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Microfluidic Immunostaining System Enables Quality Assured and Standardized Immunohistochemical Biomarker Analysis.
    Kwon S; Cho CH; Kwon Y; Lee ES; Park JK
    Sci Rep; 2017 Apr; 7():45968. PubMed ID: 28378835
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunohistochemistry Microarrays.
    Li H; Brewer G; Ongo G; Normandeau F; Omeroglu A; Juncker D
    Anal Chem; 2017 Sep; 89(17):8620-8625. PubMed ID: 28763195
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experimental validation of peptide immunohistochemistry controls.
    Bogen SA; Vani K; McGraw B; Federico V; Habib I; Zeheb R; Luther E; Tristram C; Sompuram SR
    Appl Immunohistochem Mol Morphol; 2009 May; 17(3):239-46. PubMed ID: 19077907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.